U.S. AI-Enabled Clinical Decision Support Market - Size, Share, Segmentation, Regional Insights, Key Players & Forecast, 2026–2035

The U.S. AI-Enabled Clinical Decision Support (CDS) Market is a critical and fast-evolving segment of the broader healthcare artificial intelligence ecosystem. AI-enabled CDS solutions support clinicians by delivering real-time, patient-specific, evidence-based insights that enhance diagnostic accuracy, therapeutic decisions, medication safety, and preventive care.

In 2025, the U.S. AI-enabled CDS market was valued at approximately USD 2.35 billion. Driven by rising clinical complexity, widespread electronic health record (EHR) adoption, and increasing pressure to improve care quality while controlling costs, the market is projected to reach approximately USD 13.9 billion by 2035, growing at a CAGR of 19% during 2026–2035. This growth trajectory aligns closely with overall U.S. healthcare AI expansion trends.

Modern AI-enabled CDS platforms have transitioned from static, rule-based alerts to adaptive clinical intelligence systems that continuously learn from real-world clinical data. These solutions are increasingly viewed as clinical copilots, supporting, not replacing, physician judgment across care settings.

Introduction

According to the U.S. AI-Enabled Clinical Decision Support Market Report, clinical decision support represents one of the most mature and trusted applications of artificial intelligence in U.S. healthcare. Physicians and care teams operate in a highly complex environment shaped by aging populations, chronic disease prevalence, workforce shortages, and administrative burden.

AI-enabled CDS systems address these challenges by aggregating and analyzing structured and unstructured clinical data, including lab results, imaging, physician notes, and historical outcomes, to generate context-aware recommendations at the point of care. Strong digital health infrastructure, regulatory clarity around software-as-a-medical-device (SaMD), and deep integration with EHR systems have positioned the U.S. as the global leader in CDS innovation and adoption.

Key Market Drivers: What’s Fueling the U.S. AI-Enabled CDS Market?

• Increasing Clinical Complexity and Data Overload
  U.S. clinicians manage growing volumes of clinical data across fragmented systems. AI-enabled CDS tools consolidate and contextualize this information, helping clinicians focus on the most relevant insights.
• Need for Faster, More Consistent Clinical Decisions
  In high-acuity environments such as emergency medicine, critical care, oncology, and cardiology, AI-driven CDS systems help prioritize patients, flag time-sensitive conditions, and reduce variability in decision-making.
• Deep Integration with EHR Ecosystems
  Tight integration with dominant U.S. EHR platforms such as Epic and Oracle Health (Cerner) ensures CDS insights are delivered seamlessly within clinician workflows.
• Shift Toward Value-Based and Outcome-Driven Care
  AI-enabled CDS supports guideline adherence, reduces unwarranted variation, and helps providers meet quality benchmarks tied to reimbursement.

Innovation in Focus: Advancements in AI-Enabled CDS

Manufacturers are increasingly focusing on explainable AI (XAI) to enhance clinician trust, regulatory acceptance, and accountability. Cloud-native architectures, interoperability standards (FHIR, HL7), and continuous model learning enable scalable, enterprise-wide CDS deployments across U.S. healthcare systems.

Recent Developments

FDA clearances, enterprise hospital deployments, and expansion of HIPAA-compliant cloud AI platforms continue to accelerate AI-enabled CDS adoption across U.S. healthcare systems.

Conclusion

The U.S. AI-Enabled Clinical Decision Support Market is evolving into foundational clinical infrastructure. With growing clinician trust, strong regulatory alignment, and expanding use cases, AI-enabled CDS platforms are positioned to significantly improve care quality, efficiency, and sustainability through 2035.

• Epic Systems – Embedded AI-driven CDS within EHR workflows
• Oracle Health (Cerner) – Enterprise-scale clinical intelligence platforms
• IBM Watson Health – Predictive, evidence-based CDS analytics
• Microsoft (Nuance) – NLP-driven clinical documentation and decision support
• Google Health – Imaging-based diagnostic CDS
• Tempus – Precision oncology decision support
• Aidoc – Acute care radiology CDS
• Viz.ai – Stroke and cardiovascular CDS platforms
• PathAI – Pathology-focused AI decision support
• Paige AI – Oncology diagnostics and treatment guidance
• Health Catalyst – Clinical performance and outcomes intelligence
• NVIDIA – AI infrastructure enabling real-time CDS
• Siemens Healthineers – Imaging-centric CDS solutions
• GE HealthCare – AI-enabled clinical workflow intelligence
• Philips Healthcare – Integrated CDS across monitoring and imaging
• Butterfly Network – AI-assisted point-of-care imaging CDS
• Zebra Medical Vision – Radiology decision support algorithms
• Corti – Emergency response CDS
• BrightInsight – Regulated digital health CDS infrastructure
• Others (Emerging U.S. Startups)

• Software (Dominant)
  AI-enabled CDS software platforms represent the core of the market, delivering predictive analytics, clinical logic engines, and decision interfaces embedded directly within EHR workflows.
• Hardware
  Hardware adoption remains limited but relevant for imaging-heavy CDS applications and real-time edge-AI deployments.
• Services (Fastest-Growing)
  Implementation, customization, training, clinical validation, and ongoing optimization services are growing rapidly as providers seek tailored CDS deployments.

• Machine Learning (Dominant)
  Supports diagnostic prioritization, risk scoring, and outcome prediction across multiple clinical domains.
• Natural Language Processing (Fastest-Growing)
  Enables extraction of insights from unstructured physician notes, pathology reports, and discharge summaries.
• Deep Learning
  Used in complex imaging and oncology-focused CDS use cases.
• Context-Aware Computing
  Emerging technology that enables personalized recommendations based on patient-specific clinical context.

• Diagnostic Decision Support
  Helps clinicians identify potential diagnoses, prioritize abnormal findings, and reduce diagnostic errors, especially in imaging-intensive and high-volume environments.
• Therapeutic Decision Support
  Guides treatment selection by aligning patient data with clinical guidelines, real-world evidence, and institutional protocols.
• Medication & Safety Management
  Provides alerts for drug interactions, allergies, contraindications, and dosing risks to improve patient safety.
• Predictive & Preventive Intelligence
  Identifies patients at risk of deterioration, complications, or readmissions, enabling proactive intervention.

• Hospitals & Integrated Delivery Networks (Dominant)
  Largest adopters due to complex patient populations, high data volumes, and advanced IT infrastructure.
• Physician Groups & Specialty Practices
  Use CDS to enhance diagnostic accuracy, workflow efficiency, and guideline adherence.
• Payers & Population Health Organizations
  Leverage CDS analytics for risk stratification, care management, and utilization optimization.

West (Largest Market Share)

California, Washington, Arizona, Colorado, Oregon, Nevada, Utah, and Others

The West region leads the U.S. AI-enabled CDS market due to its concentration of AI innovation hubs, digital-first healthcare systems, and academic medical centers. California dominates adoption, supported by large integrated delivery networks, early FDA-cleared AI deployments, and strong collaboration between technology vendors and providers. Washington and Colorado show strong uptake in cloud-based CDS platforms and population health analytics.

Northeast (High Clinical Innovation Density)

New York, Massachusetts, Pennsylvania, New Jersey, Connecticut, and Others

The Northeast benefits from advanced healthcare infrastructure and research-driven institutions. Massachusetts and New York are major hubs for oncology-focused and imaging-based CDS solutions, driven by leading academic medical centers and cancer research hospitals. Adoption is characterized by early validation studies and integration into complex care pathways.

South (Fastest-Growing Region)

Texas, Florida, Georgia, North Carolina, Tennessee, Virginia, Maryland, and Others

The South is emerging as the fastest-growing region due to large patient populations, rapid expansion of hospital networks, and modernization of healthcare IT systems. Texas and Florida lead adoption through large IDNs, while states such as North Carolina and Georgia are investing in AI-enabled CDS for chronic disease management and population health programs.

Midwest (Steady, Efficiency-Driven Growth)

Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, and Others

Midwestern healthcare providers are adopting AI-enabled CDS to improve operational efficiency, standardize care delivery, and address workforce shortages. Adoption is driven by multi-hospital systems seeking scalable, cost-effective CDS solutions integrated with existing EHR platforms.

1. U.S. AI-Enabled Clinical Decision Support Market: Market Introduction & Context

1.1 Market Definition
1.2 Scope of the Study
1.3 Research Methodology
1.3.1 Primary Data Collection
1.3.2 Secondary Data Sourcing
1.3.3 External Industry Collaborations
1.3.4 In-House Research Databases
1.3.5 Analytical Frameworks & Forecasting Models
1.3.6 Data Validation and Final Report Publishing
1.4 Key Assumptions
1.5 Market Ecosystem Overview
1.6 Stakeholder Analysis (AI CDS Vendors, EHR Providers, Healthcare Providers, Cloud Platforms, Regulators)
What this section provides: Defines the market, explains the research framework, data credibility, assumptions, and ecosystem to ensure transparency and reliability.

2. U.S. AI-Enabled Clinical Decision Support Market: Executive Summary

2.1 Key Insights & Market Snapshots
2.2 Analyst Viewpoint
2.3 Market Attractiveness Index
What this section provides: A concise overview of market size, growth outlook, competitive intensity, and strategic investment highlights.

3. U.S. AI-Enabled Clinical Decision Support Market: Market Dynamics & Outlook

3.1 Market Drivers
3.2 Drivers Impact Analysis
3.3 Market Restraints
3.4 Restraints Impact Analysis
3.5 Market Opportunities (Value-Based Care, AI Clinical Copilots, Precision Medicine)
3.6 Patent & Innovation Analysis (2020–2025)
What this section provides: Analysis of growth drivers, challenges, opportunity areas, and innovation momentum shaping the CDS market.

4. U.S. AI-Enabled Clinical Decision Support Market: Market Environment & Industry Analysis

4.1 PESTEL Analysis
4.1.1 Political
4.1.2 Economic
4.1.3 Social
4.1.4 Technological
4.1.5 Environmental
4.1.6 Legal
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Buyers
4.2.3 Bargaining Power of Suppliers
4.2.4 Threat of Substitutes
4.2.5 Competitive Rivalry
4.3 Pricing Trend Analysis by Region (2024–2030)
4.4 Value Chain & Supply Chain Analysis
4.5 Impact of Digitalization
4.6 Regulatory Framework Analysis (FDA SaMD, HIPAA, CMS)
4.7 Government Initiatives & Public Funding
4.8 Impact of Escalating Geopolitical Tensions
What this section provides: A comprehensive industry lens covering regulation, competition, pricing, value chain, and macro-environmental factors.

5. U.S. AI-Enabled Clinical Decision Support Market – By Component

5.1 Overview
5.2 Segment Share Analysis, By Component, 2025 & 2035 (%)
5.3 Software
5.4 Hardware
5.5 Services
What this section provides: Identifies component-level revenue drivers and future investment hotspots.

6. U.S. AI-Enabled Clinical Decision Support Market – By Technology

6.1 Overview
6.2 Segment Share Analysis, By Technology, 2025 & 2035 (%)
6.3 Machine Learning
6.4 Natural Language Processing (NLP)
6.5 Deep Learning
6.6 Context-Aware Computing
What this section provides: Breaks down the technological backbone enabling AI-driven CDS solutions.

7. U.S. AI-Enabled Clinical Decision Support Market – By Functionality

7.1 Overview
7.2 Segment Share Analysis, By Functionality, 2025 & 2035 (%)
7.3 Diagnostic Decision Support
7.4 Therapeutic Decision Support
7.5 Medication & Safety Management
7.6 Predictive & Preventive Intelligence
What this section provides: Highlights functional use-cases driving clinical adoption and value creation.

8. U.S. AI-Enabled Clinical Decision Support Market – By End User

8.1 Overview
8.2 Segment Share Analysis, By End User, 2025 & 2035 (%)
8.3 Hospitals & Integrated Delivery Networks
8.4 Physician Groups & Specialty Practices
8.5 Payers & Population Health Organizations
What this section provides: Explains adoption patterns and demand drivers across end-user categories.

9. U.S. AI-Enabled Clinical Decision Support Market – By Geography

9.1 Introduction
9.2 Segment Share Analysis, By Geography, 2025 & 2035 (%)

9.3 West Region
9.3.1 Regional Overview & Trends
9.3.2 West Region AI-Enabled CDS Key Players
9.3.3 West Region Market Size & Forecast, By State, 2025–2035
9.3.4 West Region Market Size & Forecast, By Component, 2025–2035
9.3.5 West Region Market Size & Forecast, By Technology, 2025–2035
9.3.6 West Region Market Size & Forecast, By Functionality, 2025–2035
9.3.7 West Region Market Size & Forecast, By End User, 2025–2035
9.3.8 California
9.3.9 Washington
9.3.10 Colorado
9.3.11 Arizona
9.3.12 Oregon
9.3.13 Others (Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, Hawaii)

9.4 Northeast Region
9.4.1 New York
9.4.2 Massachusetts
9.4.3 New Jersey
9.4.4 Pennsylvania
9.4.5 Connecticut
9.4.6 Others (Maine, Vermont, New Hampshire, Rhode Island, Delaware)

9.5 South Region
9.5.1 Texas
9.5.2 Florida
9.5.3 Georgia
9.5.4 North Carolina
9.5.5 Tennessee
9.5.6 South Carolina
9.5.7 Alabama
9.5.8 Others (Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Maryland, Virginia, West Virginia)

9.6 Midwest Region
9.6.1 Illinois
9.6.2 Ohio
9.6.3 Michigan
9.6.4 Minnesota
9.6.5 Indiana
9.6.6 Wisconsin
9.6.7 Missouri
9.6.8 Others (Iowa, Kansas, Nebraska, North Dakota, South Dakota)

What this section provides: Delivers granular regional and state-level market intelligence to identify growth hotspots and allocation strategies.

10. U.S. AI-Enabled Clinical Decision Support Market: Competitive Landscape & Company Profiles

10.1 Market Share Analysis (2025)
10.2 Company Positioning Matrix (Leaders, Innovators, Emerging Players)
10.3 Company Profiles
10.3.1 IBM
10.3.2 Google Health
10.3.3 Microsoft
10.3.4 NVIDIA
10.3.5 Epic Systems
10.3.6 Oracle Health
10.3.7 Tempus
10.3.8 Aidoc
10.3.9 PathAI
10.3.10 Viz.ai
10.3.11 Butterfly Network
10.3.12 Corti
10.3.13 Zebra Medical Vision
10.3.14 Paige AI
10.3.15 Health Catalyst
10.3.16 Cerner (Oracle Health)
10.3.17 Siemens Healthineers
10.3.18 GE HealthCare
10.3.19 Philips Healthcare
10.3.20 Others
What this section provides: Competitive benchmarking, market share insights, and strategic positioning of leading CDS vendors.

11. U.S. AI-Enabled Clinical Decision Support Market: Future Market Outlook (2025–2035)

11.1 Scenario Analysis (Optimistic, Realistic, Pessimistic)
11.2 Impact of Disruptive Technologies
11.3 Emerging Business & Clinical Trends
11.4 Business Opportunities for Startups & Established Players
What this section provides: Forward-looking insights into market evolution, risks, and growth opportunities.

12. U.S. AI-Enabled Clinical Decision Support Market: Strategic Recommendations

What this section provides: Actionable recommendations for technology vendors, healthcare providers, investors, and policymakers.

13. Disclaimer

What this section provides: Legal disclosures, limitations, and terms governing report usage.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: Market Drivers; Impact Analysis
TABLE 3: Market Restraints; Impact Analysis
TABLE 4: U.S. AI-Enabled Clinical Decision Support Market: Component Snapshot (2025)
TABLE 5: Segment Dashboard; Definition and Scope, by Component
TABLE 6: U.S. AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 7: U.S. AI-Enabled Clinical Decision Support Market: Technology Snapshot (2025)
TABLE 8: Segment Dashboard; Definition and Scope, by Technology
TABLE 9: U.S. AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 10: U.S. AI-Enabled Clinical Decision Support Market: Functionality Snapshot (2025)
TABLE 11: Segment Dashboard; Definition and Scope, by Functionality
TABLE 12: U.S. AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 13: U.S. AI-Enabled Clinical Decision Support Market: End-User Snapshot (2025)
TABLE 14: Segment Dashboard; Definition and Scope, by End-User
TABLE 15: U.S. AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)
TABLE 16: U.S. AI-Enabled Clinical Decision Support Market: Regional Snapshot (2025)
TABLE 17: Segment Dashboard; Definition and Scope, by Geography
TABLE 18: U.S. AI-Enabled Clinical Decision Support Market, by Geography, 2022–2035 (USD Million)

TABLE 19: California AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 20: California AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 21: California AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 22: California AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 23: Washington AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 24: Washington AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 25: Washington AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 26: Washington AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 27: Colorado AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 28: Colorado AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 29: Colorado AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 30: Colorado AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 31: Arizona AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 32: Arizona AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 33: Arizona AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 34: Arizona AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 35: Oregon AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 36: Oregon AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 37: Oregon AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 38: Oregon AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 39: West – Others AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 40: West – Others AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 41: West – Others AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 42: West – Others AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)
(Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, Hawaii)

TABLE 43: New York AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 44: New York AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 45: New York AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 46: New York AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 47: Massachusetts AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 48: Massachusetts AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 49: Massachusetts AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 50: Massachusetts AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 51: New Jersey AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 52: New Jersey AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 53: New Jersey AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 54: New Jersey AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 55: Pennsylvania AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 56: Pennsylvania AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 57: Pennsylvania AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 58: Pennsylvania AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 59: Connecticut AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 60: Connecticut AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 61: Connecticut AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 62: Connecticut AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 63: Northeast – Others AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 64: Northeast – Others AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 65: Northeast – Others AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 66: Northeast – Others AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)
(Maine, Vermont, New Hampshire, Rhode Island, Delaware)

TABLE 67: Texas AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 68: Texas AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 69: Texas AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 70: Texas AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 71: Florida AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 72: Florida AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 73: Florida AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 74: Florida AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 75: Georgia AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 76: Georgia AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 77: Georgia AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 78: Georgia AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 79: North Carolina AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 80: North Carolina AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 81: North Carolina AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 82: North Carolina AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 83: Tennessee AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 84: Tennessee AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 85: Tennessee AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 86: Tennessee AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 87: South Carolina AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 88: South Carolina AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 89: South Carolina AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 90: South Carolina AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 91: Alabama AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 92: Alabama AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 93: Alabama AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 94: Alabama AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 95: South – Others AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 96: South – Others AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 97: South – Others AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 98: South – Others AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)
(Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, West Virginia)

TABLE 99: Illinois AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 100: Illinois AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 101: Illinois AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 102: Illinois AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 103: Ohio AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 104: Ohio AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 105: Ohio AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 106: Ohio AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 107: Michigan AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 108: Michigan AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 109: Michigan AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 110: Michigan AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 111: Minnesota AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 112: Minnesota AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 113: Minnesota AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 114: Minnesota AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 115: Indiana AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 116: Indiana AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 117: Indiana AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 118: Indiana AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 119: Wisconsin AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 120: Wisconsin AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 121: Wisconsin AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 122: Wisconsin AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 123: Missouri AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 124: Missouri AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 125: Missouri AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 126: Missouri AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)

TABLE 127: Midwest – Others AI-Enabled Clinical Decision Support Market, by Component, 2022–2035 (USD Million)
TABLE 128: Midwest – Others AI-Enabled Clinical Decision Support Market, by Technology, 2022–2035 (USD Million)
TABLE 129: Midwest – Others AI-Enabled Clinical Decision Support Market, by Functionality, 2022–2035 (USD Million)
TABLE 130: Midwest – Others AI-Enabled Clinical Decision Support Market, by End-User, 2022–2035 (USD Million)
(Iowa, Kansas, Nebraska, North Dakota, South Dakota)

List of Figures

FIGURE 1: U.S. AI-Enabled Clinical Decision Support Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: PESTEL Analysis
FIGURE 5: Porter’s Five Forces Analysis
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: Market Dynamics
FIGURE 8: Innovation & Patent Landscape (2020–2025)
FIGURE 9: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 10: Component Segment Market Share Analysis, 2025 & 2035
FIGURE 11: Component Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 12: Technology Segment Market Share Analysis, 2025 & 2035
FIGURE 13: Technology Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 14: Functionality Segment Market Share Analysis, 2025 & 2035
FIGURE 15: Functionality Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 16: End-User Segment Market Share Analysis, 2025 & 2035
FIGURE 17: End-User Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 18: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Regional Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 20: West Region AI-Enabled Clinical Decision Support Market Share and Leading Players, 2024
FIGURE 21: Northeast Region AI-Enabled Clinical Decision Support Market Share and Leading Players, 2024
FIGURE 22: South Region AI-Enabled Clinical Decision Support Market Share and Leading Players, 2024
FIGURE 23: Midwest Region AI-Enabled Clinical Decision Support Market Share and Leading Players, 2024
FIGURE 24: West Region Market Share Analysis by State, 2024
FIGURE 25: California AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 26: Washington AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 27: Colorado AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 28: Arizona AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 29: Oregon AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 30: Others (West Region) AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 31: South Region Market Share Analysis by State, 2024
FIGURE 32: Texas AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 33: Florida AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 34: Georgia AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 35: North Carolina AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 36: Tennessee AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 37: South Carolina AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 38: Alabama AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 39: Others (South Region) AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 40: Midwest Region Market Share Analysis by State, 2024
FIGURE 41: Illinois AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 42: Ohio AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 43: Michigan AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 44: Minnesota AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 45: Indiana AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 46: Wisconsin AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 47: Missouri AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 48: Others (Midwest Region) AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 49: Northeast Region Market Share Analysis by State, 2024
FIGURE 50: New York AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 51: Massachusetts AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 52: New Jersey AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 53: Pennsylvania AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 54: Connecticut AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 55: Others (Northeast Region) AI-Enabled Clinical Decision Support Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)